Innoviva (INVA) EBITDA (2010 - 2026)

Innoviva's EBITDA history runs 17 years deep, the most recent figure standing at $38.2 million for Q1 2026.

• Quarterly EBITDA fell 7.9% year-over-year to $38.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $197.8 million (down 5.48% YoY) and the FY2025 annual result came in at $163.7 million, down 1.87% from the prior year.
• EBITDA was $38.2 million for Q1 2026 at Innoviva, up from -$13.8 million in the prior quarter.
• Across five years, EBITDA topped out at $131.3 million in Q3 2023 and bottomed at -$31.3 million in Q2 2023.
• A 5-year average of $28.5 million and a median of -$6.6 million in 2023 frame the typical range for EBITDA.
• Annual changes were most pronounced in 2022 — EBITDA slumped 124.9% — and 2025, when it surged 346.51%.
• Innoviva's EBITDA stood at -$10.3 million in 2022, then soared by 36.31% to -$6.6 million in 2023, then tumbled by 60.22% to -$10.5 million in 2024, then slumped by 31.16% to -$13.8 million in 2025, then soared by 376.02% to $38.2 million in 2026.
• Business Quant data shows INVA's EBITDA at $38.2 million in Q1 2026, -$13.8 million in Q4 2025, and $124.8 million in Q3 2025.